Acute occlusions of cerebral arterial vessels-intravenous versus intraarterial thrombolysis;Akute verschlüsse der hirnarterien-intravenöse oder intraarterielle thrombolyse

Therapeutische Umschau

Volumn 69, Issue 9, 2012, Pages 511-516

  Heldner, Mirjam R ^a   Gralla, Jan ^b   Hungerbühler, Hansjörg ^c   Fischer, Urs ^a   Arnold, Marcel ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Inselspital   (Switzerland)

^c CANTONAL HOSPITAL AARAU   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ARTICLE; BRAIN ISCHEMIA; DISABILITY; EMERGENCY CARE; EMERGENCY WARD; FIBRINOLYTIC THERAPY; HUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE;

ACUTE DISEASE; ANGIOEDEMA; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR DISORDERS; DIFFUSION MAGNETIC RESONANCE IMAGING; EMERGENCY SERVICE, HOSPITAL; HEMORRHAGE; HUMANS; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; STROKE; THROMBOLYTIC THERAPY;

EID: 84865591852     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930/a000323     Document Type: Article

References (31)

1. Hermann DM, Steiner T, Diener HC. Vaskuläre Neurologie. Erste Aus gabe. Stuttgart; Thieme Pub: 2010.
2. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome. A meta-analysis. Stroke 2007; 38: 967-973.
3. Saqqur M, Uchino K, Demchuk AM, et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombo lysis for stroke. Stroke 2007; 38: 948-954.
4. Koh JS, Lee SJ, Ryu CW, Kim HS. Safety and efficacy of mechanical thrombectomy with solitaire stent retrieval for acute ischemic stroke: a systematic review. Neurointervention 2012; 7: 1-9.
5. Jansen O, Brückmann H. Interventionelle Therapie des Schlaganfalls. Erste Ausgabe. Stuttgart; Thieme Pub: 2011.
6. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. NEJM 1995; 333: 1581-1587.
7. Hacke W, Kaste M, Bluhmki E, et al. ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. NEJM 2008; 359: 1317-1329.
8. Layton KF, White JB, Cloft HJ, Kallmes DF, Manno EM. Expanding the treatment window with mechanical thrombectomy in acute ischemic stroke. Neuroradiology 2006; 48: 402-404.
9. Mattle HP, Arnold M, Georgiadis D, et al. Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke 2008; 39: 379-383.
10. Nolte SH, Endres M. Management of acute ischemic stroke. Internist 2012; 53: 585-592; quiz 592-594.
11. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolyis in stroke-monitoring study (SITS-MOST): An observational study. Lancet 2007; 369: 275-282.
12. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANIS study: A randomized controlled trial. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. JAMA 1999; 282: 2019-2026.
13. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study. (ECASS). JAMA 1995; 274: 1017-1025.
14. Hacke W, Kaste M, Fieschi C, et al. Randomized double-blind placebo controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke. (ECASS II). Lancet 1998; 352: 1245-1251.
15. Hacke W, Donnan G, Fieschi C, et al. ATLANTIS Trials In vestigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators. Association of out come with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363: 768-774.
16. Wahlgren N, Ahmed N, Davalos O, et al. Thrombolysis with alteplase 3-4.5 h after acute ischemic stroke (SITS-ISTR): an observational study. Lancet 2008; 372: 1303-1309.
17. Ringleb PA, Schwark C, Köhrmann M, et al. Thrombolytic therapy for acute ischemic stroke in octogenarians: selection by magnetic resonance improves safety but does not improve outcome. J Neurolog Neurosurg Psychiat 2007; 78: 690-693.
18. Arnold M, Steinlin M, Baumann A, et al. Thrombolysis in childhood stroke: report of 2 cases and review of the literature. Stroke 2009; 40:801-807.
19. Parson M, Spratt N, Bivard A, et al. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. NEJM 2012; 366: 1099-1107.
20. Zeumer H, Hacke W, Kolmann HL, Poeck K. Lokale Fibrinolysetherapie bei Basilaristhrombose. Dtsch Med Wschr 1982; 107: 728-731.
21. Nagel S, Schellinger PD, Hartmann M, et al. Therapy of acute basilar artery occlusion: Intraarterial thrombolysis alone vs. bridging therapy. Stroke 2009; 40: 140-146.
22. Ciccone A, Valvassori L, Ponzio M, et al. Intra-arterial or intravenous thrombolysis for acute ischemic stroke? The SYNTHESIS pilot trial. J Neurointerv Surg 2010; 2: 74-79.
23. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999; 282: 2003-21011.
24. Karamashev A, Arnold M, Schroth G, et al. Diffusion-weighted MRI helps predict outcome in basilar artery occlusion patients treated with intra-arterial thrombolysis. Cerebrovasc Dis 2011; 32: 393-400.
25. Fischer U, Mono ML, Schroth G, et al. Endovascular Therapy in Acute Symptomatic Occlusion of the Internal Carotid Artery: Outcome of 201 Patients. 2012; [submitted].
26. Donnan GA, Baron JC, Ma H, Davis SM. Penumbral selection of patients for trials of acute stroke therapy. Lancet Neurol 2009; 8: 261-269.
27. Thomalla G, Cheng B, Ebinger M, et al. DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4.5 h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet 2011; [Epub ahead of print].
28. Ebinger M, Scheitz JF, Kufner A, Endres M, Fiebach JB, Nolte CH. MRI-based intravenous thrombolysis in stroke patients with unknown time of symptom onset. Eur J Neurol 2012; 19: 348-350.
29. Adams HP,del Zoppo G, Alberts MJ., et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology, Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 2007; 115: e478.
30. Brott T, Bogousslavsky J. Treatment of acute ischemic stroke. NEJM 2000; 343: 710-722.
31. Lichy C, Hacke W. Stroke. Internist 2010; 51: 1003-1011.